Evidence map›Paper›PMID 41184638›Full record

ArticleNature medicine2025

Physical activity as a modifiable risk factor in preclinical Alzheimer's disease.

Wai-Ying Wendy Yau, Dylan R Kirn, Jennifer S Rabin, Michael J Properzi, Aaron P Schultz, Zahra Shirzadi, Kailee Palmgren, Paola Matos, Courtney Maa, Jeremy J Pruzin and 6 more

Abstract read
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Prospective study on physical activity and Alzheimer's disease-related biomarkers.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Is Alzheimer's an Autoimmune Disease?Molecular neurobiology · 2026
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wai-Ying Wendy YauDepartment of Neurology, Mass General Brigham, Boston, MA, USA. wyau@mgb.org.ORCID http://orcid.org/0000-0002-7597-7647
Dylan R KirnDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Jennifer S RabinHarquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-4754-2221
Michael J ProperziDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Aaron P SchultzDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Zahra ShirzadiDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Kailee PalmgrenDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Paola MatosDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Courtney MaaDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Jeremy J PruzinDepartment of Neurology, Banner Alzheimer's Institute, Phoenix, AZ, USA.
Stephanie A SchultzDepartment of Neurology, Mass General Brigham, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8460-4415
Rachel F BuckleyDepartment of Neurology, Mass General Brigham, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5356-5537
Dorene M RentzDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Keith A JohnsonDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Reisa A SperlingDepartment of Neurology, Mass General Brigham, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1535-6133
Jasmeer P ChhatwalDepartment of Neurology, Mass General Brigham, Boston, MA, USA. chhatwal.jasmeer@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-7792-1698

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rachel Frances Buckley · 2010 to 2026
$50.2M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
Project 4P41EB015896 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2012 to 2018
$9.8M
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's DiseaseR01AG062667 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CHHATWAL, JASMEER P · 2019 to 2024
$4.2M
Plasma tau and neurodegenerative markers as predictors of rate of AD progressionR01AG071865 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CHHATWAL, JASMEER P · 2021 to 2025
$4.2M
A Storage Area Network for Structural and Functional Image AnalysisS10RR023401 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE · 2009 to 2009
$2.0M
SILICON GRAPHICS PRISM EXTREME 128P/1TBS10RR023043 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, ALMA GREGORY · 2006 to 2006
$1.5M
Mentoring Imaging Research in Early ADK24AG035007 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SPERLING, REISA A. · 2010 to 2020
$1.4M
Elevated systolic blood pressure, body mass index, and amyloid as drivers of tau and cognitive decline in preclinical Alzheimers disease: critical windows in mid- to late-lifeK23AG084868 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Wai-Ying Wendy Yau · 2024 to 2026
$587k
A Siemens MAGNETOTOM Trio 3 Tesla MRI SystemS10RR021110 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2006 to 2006
$500k
Identifying variations in gamma-secretase function that are critical determinants of clinical and biomarker progression of Autosomal Dominant Alzheimer's disease: From mechanism to clinical trialsK01AG084816 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Stephanie Schultz · 2024 to 2026
$387k
Doris Duke Charitable Foundation (DDCF) Clinical Scientist Development AwardNCRR NIH HHS S10 RR021110NCRR NIH HHS S10 RR023043NCRR NIH HHS S10 RR023401NIA NIH HHS K01 AG084816NIA NIH HHS K23 AG084868NIA NIH HHS K24 AG035007NIA NIH HHS P01 AG036694NIA NIH HHS P30 AG062421NIA NIH HHS R01 AG062667NIA NIH HHS R01 AG071865NIBIB NIH HHS P41 EB015896
6 · The paper itself

Abstract

Physical inactivity is a recognized modifiable risk factor for Alzheimer's disease (AD), yet its relationship with progression of AD pathology in humans remains unclear, limiting the effective translation into prevention trials. Using pedometer-measured step counts in cognitively unimpaired older adults, we demonstrated an association between higher physical activity and slower cognitive and functional decline in individuals with elevated baseline amyloid. Importantly, this beneficial association was not related to lower amyloid burden at baseline or longitudinally. Instead, higher physical activity was associated with slower amyloid-related inferior temporal tau accumulation, which significantly mediated the association with slower cognitive decline. Dose-response analyses further revealed a curvilinear relationship, where the associations with slower tau accumulation and cognitive decline reached a plateau at a moderate level of physical activity (5,001-7,500 steps per day), potentially offering a more approachable goal for older sedentary individuals. Collectively, our findings support targeting physical inactivity as an intervention to modify the trajectory of preclinical AD in future prevention trials, and further suggest that preferentially enrolling sedentary individuals with elevated amyloid may maximize the likelihood of demonstrating a protective effect of physical activity on tau accumulation and cognitive and functional decline in early AD.

Indexed as

Alzheimer DiseaseExerciseAgedAged, 80 and overCognitionCognitive DysfunctionFemaleHumansMaleRisk FactorsSedentary Behaviortau Proteinstau Proteins

Identifiers

PMID41184638
PMCPMC12705434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.